Karrels James
- SEC CIK
- 0001587477
No open-market purchases or sales filed in the past year.
Current role at each company
- MGNX Macrogenics IncSVP and CFOas of Feb 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Karrels James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Karrels JamesSVP, CFO and Secretary | SSale | −30.0K | $20.50 | −$615.0K | −14.9%171.5K after | 10b5-1 |
| Jun 17, 2022 (view filing) | Jun 15 | 2 days | Karrels JamesSVP, CFO and Secretary | PPurchase | +40.0K | $2.47 | +$98.8K | +26.4%191.8K after |